Fresenius SE & Co. KGaA (FSNUY): Price and Financial Metrics


Fresenius SE & Co. KGaA (FSNUY): $13.86

0.11 (+0.77%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

FSNUY Stock Price Chart Interactive Chart >

Price chart for FSNUY

FSNUY Price/Volume Stats

Current price $13.86 52-week high $14.81
Prev. close $13.75 52-week low $9.17
Day low $13.79 Volume 9,900
Day high $13.87 Avg. volume 28,751
50-day MA $12.85 Dividend yield 1.3%
200-day MA $11.55 Market Cap 30.83B

Fresenius SE & Co. KGaA (FSNUY) Company Bio


Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs, including intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products that are used in the collection and processing of blood components, as well as in transfusion medicine and cell therapy. As of December 31, 2019, this segment operated 86 hospitals, approximately 125 outpatient clinics, and 8 prevention centers. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. Fresenius SE & Co. KGaA has a strategic partnership with Humacyte Inc. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.


FSNUY Latest News Stream


Event/Time News Detail
Loading, please wait...

FSNUY Latest Social Stream


Loading social stream, please wait...

View Full FSNUY Social Stream

FSNUY Price Returns

1-mo 1.71%
3-mo 28.69%
6-mo 18.89%
1-year 16.82%
3-year -29.56%
5-year -16.96%
YTD 20.52%
2020 -15.33%
2019 16.16%
2018 -37.01%
2017 0.26%
2016 9.13%

FSNUY Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full FSNUY Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7922 seconds.